Video Library

14 Jun 2022

hVIVO’s £7.2m RSV Human Challenge Model Contract

01 Jun 2022

Open Orphan racks up another ‘first’ with £14.7mln full-service flu contract

19 May 2022

Chief Scientific Officer on Influenza Challenge Study contract Win

15 Jun 2022

LSX World Congress Showcase Open Orphan

09 Mar 2022

London South East were delighted to host Open Orphan, Orosur, Petro Matad, Aura Minerals last night

08 Mar 2022

Open Orphan sticks to 2021 earnings guidance as it announces an expansion of its facilities

08 Mar 2022

Volunteer Recruitment & Laboratory Facilities Expansion – Robin Rogiers & BRR Media

24 Feb 2022

CEO Appointment at Open Orphan

24 Feb 2022

Open Orphan announce Yamin ‘Mo’ Khan as new CEO

17 Feb 2022

hVIVO hail data on phase 2a study published in New England Journal of Medicine

14 Feb 2022

Open Orphan subsidiary hVIVO launch of STRiVE to ‘find out what people are actually suffering from’

14 Feb 2022

Adrian Wildfire on hVIVO STRiVE Project

02 Feb 2022

Open Orphan’s Cathal Friel presents results from world’s first COVID-19 characterisation study

02 Feb 2022

Open Orphan present ‘invaluable’ key findings of world’s first COVID-19 characterisation study

02 Feb 2022

CSO Andrew Catchpole on the world’s first COVID-19 Characterisation Study

24 Jan 2022

Executive Chairman Cathal Friel on The world’s first COVID-19 Characterisation Study

24 Jan 2022

Adrian Wildfire hVIVO Malaria Challenge Agent – BRR Media

20 Jan 2022

BRR Interview Cathal Friel on Malaria Human challenge agent

20 Jan 2022

Open Orphan’s Cathal Friel on the ‘large opportunity’ for hVIVO subsidiary malaria study

20 Jan 2022

Open Orphan’s hVIVO subsidiary begin study for human malaria infection challenge study

21 Dec 2021

Open Orphan hail £5m contract for new flu jab challenge study

24 Aug 2021

Cathal Friel and BRR Media Discuss £8.1m Asthma Human Challenge Study Contract Win

20 Jul 2021

Open Orphan announce ‘substantial contract wins’ with an existing client and UK government

07 Jun 2021

FluCamp Hotel Quarantine Facility – Bedroom Tour

09 Apr 2021

Open Orphan: Global Leader in Human Challenge Vaccine Development | Executive Chairman Cathal Friel

17 Feb 2021

Open Orphan to become ‘$1bln firm in very near future’ after COVID-19 study receives ethics approval

16 Dec 2020

hVIVO secure MHRA approval to start Codagenix COVID-19 Phase I Vaccine Trial

16 Dec 2020

Shares Investor Evening with Cathal Friel December 2020

15 Dec 2020

Codagenix Covid vaccine phase I study approval interview on Sky News with Cathal Friel

07 Dec 2020

Open Orphan 2020 Year in Review

20 Nov 2020

COVID-19: UK scientists to infect volunteers with coronavirus in world first vaccine trial

20 Oct 2020

Young people to be deliberately exposed to Covid-19 to speed up vaccine development

20 Oct 2020

Market Coverage: Tuesday October 20 Yahoo Finance

06 Oct 2020

Shares Magazine Investor Evening October 2020

06 Oct 2020

Open Orphan Dual Business Firing on All Four Cylinders

01 Oct 2020

Open Orphan Interim Results Interview with BRR Media

10 Aug 2020

Interview with Proactive Investors following £4M contract with Top 3 Global Pharma company

17 Jun 2020

Open Orphan pushes ahead with hVIVO COVID Clear, the ‘most accurate’ antibody test

08 Jun 2020

Coronavirus: I took a COVID-19 antibody test to see if I’d had coronavirus without realising it

05 Jun 2020

Shares Magazine Open Orphan (ORPH) Presentation – Cathal Friel, Executive Chairman

06 Nov 2015

hVIVO – Introduction to our Quarantine & Medical Facilities

26 May 2015

BBC – The truth about your medicine cabinet

15 Sep 2014

hVIVO (formerly, and at the time of filming, Retroscreen) on BBC1 The One Show September 2014

11 May 2015

FluCamp – what it is like to participate in a clinical trial

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO